1. Home
  2. CRIS vs TPCS Comparison

CRIS vs TPCS Comparison

Compare CRIS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • TPCS
  • Stock Information
  • Founded
  • CRIS 2000
  • TPCS 1956
  • Country
  • CRIS United States
  • TPCS United States
  • Employees
  • CRIS N/A
  • TPCS N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • TPCS Metal Fabrications
  • Sector
  • CRIS Health Care
  • TPCS Industrials
  • Exchange
  • CRIS Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • CRIS 32.8M
  • TPCS 31.5M
  • IPO Year
  • CRIS 2000
  • TPCS N/A
  • Fundamental
  • Price
  • CRIS $3.22
  • TPCS $3.19
  • Analyst Decision
  • CRIS Strong Buy
  • TPCS
  • Analyst Count
  • CRIS 3
  • TPCS 0
  • Target Price
  • CRIS $23.00
  • TPCS N/A
  • AVG Volume (30 Days)
  • CRIS 39.9K
  • TPCS 22.8K
  • Earning Date
  • CRIS 02-14-2025
  • TPCS 01-21-2025
  • Dividend Yield
  • CRIS N/A
  • TPCS N/A
  • EPS Growth
  • CRIS N/A
  • TPCS N/A
  • EPS
  • CRIS N/A
  • TPCS N/A
  • Revenue
  • CRIS $10,259,000.00
  • TPCS $33,182,059.00
  • Revenue This Year
  • CRIS N/A
  • TPCS N/A
  • Revenue Next Year
  • CRIS N/A
  • TPCS N/A
  • P/E Ratio
  • CRIS N/A
  • TPCS N/A
  • Revenue Growth
  • CRIS 0.44
  • TPCS 6.44
  • 52 Week Low
  • CRIS $2.86
  • TPCS $2.85
  • 52 Week High
  • CRIS $17.49
  • TPCS $5.95
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.34
  • TPCS 43.57
  • Support Level
  • CRIS $3.05
  • TPCS $3.09
  • Resistance Level
  • CRIS $3.55
  • TPCS $3.25
  • Average True Range (ATR)
  • CRIS 0.24
  • TPCS 0.13
  • MACD
  • CRIS 0.03
  • TPCS 0.01
  • Stochastic Oscillator
  • CRIS 47.53
  • TPCS 26.67

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

Share on Social Networks: